Anaïs Hagege

Synthesis and biological evaluation of 3-amino-1,2,4-triazole derivatives as potential anticancer compounds

Oleksandr Grytsai, Oksana Valiashko, Manon Penco-Campillo et al. · Bioorganic Chemistry · 2020 · 72 citations · Full text

Medicine, Medicinal Chemistry, Oncology +14

Soluble forms of PD-L1 and PD-1 as prognostic and predictive markers of sunitinib efficacy in patients with metastatic clear cell renal cell carcinoma

Christopher Montemagno, Anaïs Hagege, Delphine Borchiellini et al. · OncoImmunology · 2020 · 66 citations · Full text

Medicine, Cancer Biology, Oncology +17

New CXCR1/CXCR2 inhibitors represent an effective treatment for kidney or head and neck cancers sensitive or refractory to reference treatments

Maeva Dufies, Oleksandr Grytsai, Cyril Ronco et al. · Theranostics · 2019 · 61 citations · Full text

Medicine, Oncology, Pharmacology +7

Plk1, upregulated by HIF-2, mediates metastasis and drug resistance of clear cell renal cell carcinoma

Maeva Dufies, Annelies Verbiest, Lindsay S. Cooley et al. · Communications Biology · 2021 · 42 citations · Full text

Medicine, Cancer Biology, Oncology +17

The Polo-like kinase 1 inhibitor onvansertib represents a relevant treatment for head and neck squamous cell carcinoma resistant to cisplatin and radiotherapy

Anaïs Hagege, Damien Ambrosetti, Julien Boyer et al. · Theranostics · 2021 · 39 citations · Full text

Medicine, Oncology, Pharmacology +17